BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 209 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $52,118,043 | -33.2% | 2,224,415 | -5.8% | 0.04% | -29.6% |
Q1 2024 | $78,034,434 | +21.6% | 2,361,817 | +0.2% | 0.05% | +14.9% |
Q4 2023 | $64,187,237 | +62.5% | 2,358,091 | +43.6% | 0.05% | +46.9% |
Q3 2023 | $39,494,429 | +1.8% | 1,642,180 | +35.1% | 0.03% | +6.7% |
Q2 2023 | $38,797,504 | +92.4% | 1,215,080 | +84.5% | 0.03% | +100.0% |
Q1 2023 | $20,165,291 | -23.5% | 658,566 | -2.2% | 0.02% | -28.6% |
Q4 2022 | $26,348,016 | +8.2% | 673,690 | +31.9% | 0.02% | +5.0% |
Q3 2022 | $24,341,000 | +115.4% | 510,931 | +75.0% | 0.02% | +122.2% |
Q2 2022 | $11,302,000 | -30.4% | 291,962 | +3.0% | 0.01% | -18.2% |
Q1 2022 | $16,245,000 | -9.5% | 283,509 | +25.9% | 0.01% | 0.0% |
Q4 2021 | $17,948,000 | -18.9% | 225,223 | -11.5% | 0.01% | -21.4% |
Q3 2021 | $22,131,000 | -33.0% | 254,355 | -0.9% | 0.01% | -30.0% |
Q2 2021 | $33,022,000 | +79.8% | 256,565 | +11.8% | 0.02% | +81.8% |
Q1 2021 | $18,361,000 | +10.1% | 229,401 | +12.3% | 0.01% | 0.0% |
Q4 2020 | $16,674,000 | – | 204,242 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,346,934 | $90,850,000 | 40.87% |
Deep Track Capital, LP | 1,250,000 | $48,388,000 | 3.18% |
HSG Holding Ltd | 796,089 | $30,817,000 | 2.84% |
Redmile Group, LLC | 1,849,887 | $71,609,000 | 2.73% |
ARK Investment Management | 8,792,064 | $309,305,000 | 1.83% |
Evolutionary Tree Capital Management, LLC | 31,893 | $1,235,000 | 1.34% |
BRANDYWINE MANAGERS, LLC | 13,067 | $506,000 | 1.24% |
Casdin Capital, LLC | 375,000 | $14,516,000 | 1.23% |
Temasek Holdings (Private) Ltd | 3,959,212 | $153,261,097 | 0.84% |
Yiheng Capital Management, L.P. | 363,800 | $14,083,000 | 0.80% |